These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5010245)

  • 21. [Therapy of primary cancer of the lung by means of cyclophosphamide].
    Lauria D; Liotti G; Tucci M
    Clin Ter; 1965 Sep; 34(5):415-27. PubMed ID: 5851918
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
    Kanzler S; Gerken G; Dienes HP; Meyer zum Büschenfelde KH; Lohse AW
    Z Gastroenterol; 1997 Jul; 35(7):571-8. PubMed ID: 9273991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy with cyclophosphamide in O.R.L.: results in 2 cases of neoplasms of the principal respiratory tract].
    Bellomo D; Carducci A
    Arch Ital Laringol; 1965; 73(5):Suppl:105-21. PubMed ID: 5872803
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
    Rudolf Z; Plesnicar S
    Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined cytostatic treatment of solid tumours with cyclophosphamide (Endoxan), vincristine, methylaminopterin (Methotrexate) and 5-fluorouracil].
    Brincker H
    Ugeskr Laeger; 1971 May; 133(19):926-9. PubMed ID: 5559763
    [No Abstract]   [Full Text] [Related]  

  • 26. The course of nausea and vomiting after high-dose cyclophosphamide.
    Fetting JH; Grochow LB; Folstein MF; Ettinger DS; Colvin M
    Cancer Treat Rep; 1982 Jul; 66(7):1487-93. PubMed ID: 7093965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
    Perini P; Gallo P
    J Neurol; 2003 Jul; 250(7):834-8. PubMed ID: 12883926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Massive cytostatic therapy after orthovoltage therapy].
    Schawow A
    Radiobiol Radiother (Berl); 1970; 11(6):655-9. PubMed ID: 5509232
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cyclophosphamide infusion (Druckrey's "shock-therapy") in the treatment of malignant lung tumors].
    Beumer HM
    Ned Tijdschr Geneeskd; 1965 Sep; 109(36):1648-52. PubMed ID: 5318275
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcome of 85 lupus nephritis patients treated with intravenous cyclophosphamide: a single centre 10 year experience.
    Chan AY; Hooi LS
    Med J Malaysia; 2000 Mar; 55(1):14-20. PubMed ID: 11072485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors.
    Bayani N; Rugina M; Haddad-Vergnes L; Lelong F
    Am J Hematol; 2002 Sep; 71(1):33-6. PubMed ID: 12221671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of platinum plus cyclophosphamide in patients with epithelial ovarian cancer.
    Tangjitgamol S; Mamusirinitaya S; Leelahakorn S; Thawaramara T; Pataradool K; Suekwatana P; Sittidilokratna K
    J Med Assoc Thai; 2005 Sep; 88(9):1172-81. PubMed ID: 16536101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
    Huang YW; Saidi P; Philipp C
    Haemophilia; 2004 Nov; 10(6):713-21. PubMed ID: 15569166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cyclophosphamide during pregnancy: a safe prescription].
    Nguyen Tan Lung R; Granier M; Gaudry C; Kourilsky O
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):314-8. PubMed ID: 7622780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urothelial carcinoma of the bladder following cyclophosphamide therapy].
    Blume B; Rabe F; Theuring F
    Z Urol Nephrol; 1984 Jan; 77(1):7-9. PubMed ID: 6702330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical aspects and therapy of malignant melanoma].
    Storck H
    Hautarzt; 1970 Apr; 21(4):187-94. PubMed ID: 5524565
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclophosphamide--an anticancer and immunosuppressive drug.
    Med Lett Drugs Ther; 1971; 13(16):67-8. PubMed ID: 5139824
    [No Abstract]   [Full Text] [Related]  

  • 39. Good response of a paraneoplastic neuromyopathy to cyclophosphamide.
    Bruyland M; Van Belle S; Schallier D; Ebinger G; Martin JJ
    Cancer Treat Rep; 1984 May; 68(5):787-9. PubMed ID: 6327036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor VIII antibodies in rheumatoid arthritis. Effect of cyclophosphamide.
    Green D; Schuette PT; Wallace WH
    Arch Intern Med; 1980 Sep; 140(9):1232-5. PubMed ID: 6773487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.